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Abstract 
 
Background: Schizophrenia is a chronic, debilitating mental disorder characterized by positive 
(e.g., hallucinations, delusions) and negative (e.g., catatonia, flat affect) signs and symptoms. 
Many studies suggest that individuals born in winter or spring months are at increased risk for 
schizophrenia. 
 
Study Objectives: 1) To determine whether season of birth affects risk for schizophrenia in the 
Irish Study of High Density Schizophrenia Families (ISHDSF). 2) To examine, by computer 
simulation, power to detect genetic associations with schizophrenia under a variety of conditions 
and using different analytic strategies. 3) To test whether specific genes are associated with 
schizophrenia in the Irish Case Control Schizophrenia Study (ICCSS), using different analytic 
strategies to account for season of birth. 
 
Methods: A case-control design was used to examine the relationship between schizophrenia and 
season of birth. Cases were individuals from the ISHDSF diagnosed with schizophrenia. 
Controls were the general population of Ireland, with data provided by Ireland’s Central 
Statistics Office (CSO). The birth frequencies for each month or quarter were compared in the 
two groups by a chi square test. Computer simulations were conducted to examine power to 
detect schizophrenia susceptibility loci using either all cases or only cases born in high-risk 
months, under different conditions and models for how genetic risk and season of birth interact 
to influence risk for schizophrenia. Data for six genetic markers from the ICCSS were analyzed 
for evidence of association, using all cases, and then using only cases born in high-risk months. 
 
Setting and Study Participants: ISHDSF families were ascertained through inpatient psychiatric 
care facilities serving >95% of the Irish population. Diagnoses were established using DSM-III-
R criteria, and birthdates were recorded for all individuals. The Irish CSO provided aggregate, 
population-level data for number of births in Ireland by month for the years 1976-2000 and by 
quarter for the years 1900-2000. The ICCSS is a sample of schizophrenic and control individuals 
who have been genotyped at many loci across the genome. Schizophrenics were ascertained 
through in- and outpatient psychiatric facilities, had diagnoses verified by an expert, and their 
birthdates recorded. Controls were selected from several sources, e.g. blood donation centers, 
and denied any lifetime history of schizophrenia. For each subject in the ICCSS, all four 
grandparents were born in Ireland or the United Kingdom. 
 
Results: Number of births in each month was compared for schizophrenics in the ISHDSF and 
general population controls, resulting in a chi square of 19.44 (p value ~ 0.054, 11 df). 
Simulations revealed that, in some circumstances, power to detect genetic associations was 
increased by restricting cases to those born in high-risk months. Analysis of data from the ICCSS 
revealed that restricting cases to high-risk birth months increased the evidence for association for 
three of six markers tested, two of which were associated with the gene FBXL21. 
 
Conclusions: Birth in the months of March, April, or May appears to be associated with elevated 
risk for schizophrenia in the ISHDSF. In attempting to find susceptibility loci for schizophrenia, 
restricting genetic association analyses to schizophrenics born in high-risk months may result in 
increased power to detect genetic association in some circumstances. 
1 
Introduction 
 
Background and significance: 
Schizophrenia is a mental disorder characterized by abnormalities in the perception or expression 
of reality. According to the Diagnostic and Statistical Manual[1], schizophrenia includes 
characteristic symptoms, such as delusions, hallucinations, and/or grossly disorganized behavior; 
social and/or occupational dysfunction below the level achieved prior to onset of symptoms; and 
a duration of at least six months (see Box 1). Although the course of schizophrenia may be 
marked by varying degrees of recovery, complete cures are uncommon. The average duration 
that an individual lives with schizophrenia is approximately 30 years[2]. The toll of 
schizophrenia on patients and their families is considerable. Affected individuals have a 10 year 
reduction in life expectancy[3], mostly an effect of increased rates of suicide. Among the leading 
causes of disability-adjusted life years, schizophrenia ranks 8th in 15-44 year olds[4]. 
Schizophrenia is a relatively common disease. The point prevalence has been estimated at 4.6 per 
1000 persons (80% confidence intervals 1.9-10)[5]. The incidence has been estimated as 15.2 per 
100,000 persons per year (80% confidence intervals 8-43)[6]. Lifetime risk of schizophrenia is 
estimated to be 0.7%[5]. 
 
Research to identify the causes of schizophrenia has been an active area of investigation for 
decades. Although much has been learned, a recent survey of findings over the last 20 years 
concluded, "what we can confidently assert is essentially the same -- both genetic and 
environmental factors are important, but exactly which specific exposures and exactly how they 
cause schizophrenia is still unknown…”[2]. Family history of schizophrenia is a risk factor. The 
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relative risk associated with a positive family history depends on how closely related the affected 
relative is to the person at risk. Having a monozygotic twin with schizophrenia equates to a 
relative risk (RR) of 50-70, a first degree relative (e.g., a sibling) to a RR of 9-18, and a second 
degree relative to a RR of 3-6[2]. At least some of the familial risk is a consequence of specific 
genetic variants; dozens of loci within the human genome have been identified as putative 
schizophrenia susceptibility loci, although the number of replicated findings is much smaller[7]. 
The RR associated with any specific single gene variant is 1.1-1.5[2]. Non-genetic risk factors 
for schizophrenia include living in an urban environment (RR 2-3), history of migration (RR 2-
3), and use of certain illicit drugs (RR 2-3)[2]. 
 
Another putative non-genetic risk factor for schizophrenia is season of birth. Tramer first made 
the observation that among 3100 patients diagnosed with “psychosis”, there were 15% excess 
births in winter-spring months (cited in [8]). Since then, many researchers have attempted to 
replicate this finding. The most extensive single review of all these studies was that conducted by 
Torrey et al, in 1997[8]. These authors reviewed > 250 articles, spanning 34 countries in both the 
Northern and Southern Hemispheres and nearly 80 years of accumulated research. Even in the 
face of methodological inconsistencies and other shortcomings, the authors concluded that the 
studies were remarkably consistent in demonstrating a small, but significant, winter-spring birth 
excess among schizophrenics. A more recent systematic review and meta-analysis of Northern 
Hemisphere season of birth studies found a significant excess of winter/spring births compared 
to summer/autumn (pooled odds ratio 1.07)[9]. More recent articles from Japan[10], Poland[11], 
and Puerto Rico[12] have provided additional evidence to support an excess of schizophrenic 
births in winter-spring. 
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There are several prior studies that have addressed whether season of birth is a risk factor for 
schizophrenia using samples from Ireland. O’Hare et al.[13] found 11% excess births for the 
second quarter of the year in 4855 inpatients born between 1921 and 1955. O’Callaghan et 
al.[14] examined 3253 persons with schizophrenia ascertained by case registers and found a 5% 
excess of births from the first quarter, although the results were non-significant. Significant 
results were found in this same study when subjects were restricted to individuals living in urban 
environments. O’Callaghan et al.[15] examined 616 inpatients from 1983-1988 and found a 9% 
excess of schizophrenia births for the first quarter, which was not statistically significant. This 
last study further examined results from two patient subsets: those with a first-degree relative 
affected by schizophrenia and those without. Season of birth and schizophrenia were found to be 
significantly associated only in those individuals without a family history. Similar findings have 
been reported in other, non-Irish samples[16], although other researchers have found evidence 
for a season of birth effect even in individuals with a family history[17]. Hettema et al. found no 
relationship between degree of familial vulnerability to schizophrenia and season of birth in an 
Irish family study[18]. King et al.[19] studied a combination of 184 schizophrenic patients and 
60 with affective disorder from Northern Ireland and found excess schizophrenia births in 
March, April, and May. 
 
On balance then, one could reasonably conclude that 1) in most studies, season of birth does 
account for a small but significant risk for schizophrenia, 2) two of four studies using Irish 
samples found a significant association between season of birth and schizophrenia, 3) all but 
one[19] of the studies using Irish samples were limited to examining schizophrenia and quarter 
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of birth, as opposed to month of birth, and 3) there is conflicting evidence as to whether 
association of season of birth and schizophrenia is limited to those without a family history.  
 
If season of birth is associated with risk for schizophrenia, what exactly does this mean? How are 
the two related? The most probable explanation is that season of birth is a proxy variable for 
some unmeasured, seasonally varying environmental factor that influences risk in prenatal or 
early neonatal life; possibilities include meteorological variables such as temperature and light, 
maternal infections during pregnancy (e.g., influenza, rubella, etc.), and malnutrition[20]. The 
action of such a risk factor would disrupt the normal maturation of the brain in prenatal and early 
neonatal life, a concept known as the neurodevelopmental hypothesis[21]. Seasonal variation in 
exposure to this unmeasured environmental risk factor combined with vulnerability only during 
prenatal or early neonatal life would translate into the observed excess of schizophrenic births at 
certain times of the year.  
 
Individual human genetic variation is thought to be an important determinant of the response to 
various environmental exposures, including infections[22] and nutrition[23]. Thus, it is not 
unreasonable to expect that genetic and environmental factors might also interact to produce risk 
for psychiatric disorders, including schizophrenia. This concept is supported by the observation 
that schizophrenia is known to be associated with various environmental factors (see above), but 
there is apparently considerable variation in individual response to these environments[24]. In 
fact, indirect evidence that gene-environment interactions influence risk for schizophrenia has 
already been adduced, using proxy genetic variables (e.g., positive family history) and 
environments (reviewed in [24]). In the case of season of birth and schizophrenia, this concept 
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translates to the hypothesis that different individuals react differently to the exposure indexed by 
season of birth, depending on their genotype. This particular type of gene-environment 
interaction is also known as “genetic control of sensitivity to the environment[25].” For example, 
in the case of maternal infections, this hypothesis would state that certain individuals have 
genotypes that make them quite vulnerable to the effect of maternal infections during their in 
utero development, while other individuals with different genotypes are relatively invulnerable. 
In this scenario, the combination of the “wrong” genotype with a “bad” season of birth--a proxy 
for the likelihood of maternal infection during a critical period of pregnancy--would increase risk 
for schizophrenia beyond that expected from simply adding the risks of the two factors.  
 
If gene-environment interaction of the type discussed above does underlie the apparent 
relationship of schizophrenia and season of birth, might this suggest an alternative approach to 
detecting susceptibility loci? In gene association studies, one typically compares genotype 
frequencies in a set of cases and controls. If differences are found, this is taken as evidence that 
gene variants at that locus may confer risk for the phenotype under study. Alternatively, one 
could restrict the set of schizophrenics to those exposed to the environmental risk factor, i.e., 
those born in high-risk months. Such an approach would necessarily result in a reduced sample 
size, since only the exposed cases would be included. However, the loss of power associated 
with a smaller sample could potentially be more than offset by a gain in power due to increased 
effect size in a more homogenous subgroup, as would be the case if genotype and phenotype 
were more strongly associated in exposed individuals. This leads to the following question: 
under what specific conditions, i.e., combination of sample size, effect size, etc., does use of 
exposed cases only result in increased overall power to detect genetic associations? Further, 
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which variables are most important in determining power? Finally, could such an approach 
actually result in increased evidence for genetic association when applied to real data? 
 
Objectives 
1) The Irish Study of High Density Schizophrenia Families (ISHDSF) is a study of high-density 
schizophrenia families from Ireland and Northern Ireland. This sample has not previously been 
examined for evidence of excess schizophrenic births in winter-spring. Dates of birth are 
recorded for nearly all individuals in the sample. Because of the inclusion criteria, schizophrenic 
individuals in this sample represent familial, as opposed to sporadic, cases of schizophrenia. 
Given the findings from the literature above, it is of interest to examine whether there is an 
excess of schizophrenic births in winter-spring months in this sample, especially in light of the 
controversy as to whether the schizophrenia-season of birth relationship is confined to non-
familial cases. Also, monthly birth figures for the general population of Ireland were obtained for 
use as controls. It is of interest to analyze the data by month, since most previous studies of Irish 
samples categorized birth by quarter. For these reasons, the first objective of this work is to 
determine whether season of birth differs between schizophrenics from the ISHDSF and general 
population controls by month and also by quarter. 
 
2) As discussed above, the most powerful analytic strategy to detecting genetic associations with 
schizophrenia, assuming gene-environment interaction, is unclear. However, the most powerful 
strategy will likely depend on specific parameters such as sample size, gene effect size, etc. 
Computer simulations, incorporating pre-specified event probabilities, can be extremely valuable 
in uncovering general trends and important factors that determine the power of a given statistical 
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test. For these reasons, the second objective of this study is to examine, by computer simulation, 
power to detect the association of a susceptibility locus and schizophrenia under a variety of 
assumptions, including different models for the interaction of genetic risk and season of birth in 
determining schizophrenia. It is of particular interest to compare analyses using all cases, and 
analyses using cases only born in high-risk months. 
 
3) The Irish Case Control Schizophrenia Study (ICCSS) is a case-control study designed to 
identify genetic loci associated with schizophrenia. Genotypes at multiple marker loci are 
available for individuals in this sample. Birthdates are available for schizophrenics in the sample. 
The third objective of this study is to examine six markers for evidence of association to 
schizophrenia using the two analytic strategies explored in the simulations above, i.e., with all 
cases and then with cases born in high-risk months. This is meant primarily to illustrate the 
analytic strategies employed in the simulations using actual, real-world data. 
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Methods 
 
Season of birth and risk for schizophrenia in Ireland 
 
Design: This case-control study was conducted using the Irish Study of High Density 
Schizophrenia Families (ISHDSF) to identify cases, and the general population of Ireland, as 
provided by Ireland’s Central Statistics Office (CSO), as controls. It was assumed that the 
prevalence of schizophrenia in the entire population of Ireland is low enough so that, any 
relationship that may exist between schizophrenia and season of birth would have little or no 
effect on statistics calculated using the general population as controls. General population data 
have been used previously as controls in studies of season of birth and schizophrenia[26]. 
  
The study hypothesis was that an excess of schizophrenic births exists in winter-spring months. 
This study tested this hypothesis by comparing birth frequencies, by month and by quarter, in 
schizophrenic cases to expected values based on general population controls. 
 
Sample and Data Collection: The source of cases, the ISHDSF, has been described in detail 
elsewhere[27]. Fieldwork for this study was completed between April, 1987 and November, 
1992. The sample was initially conceived for the purposes of genome-wide searches for 
schizophrenia susceptibility loci. Prior research had indicated that, while genetic factors are a 
major part of an individual’s risk for schizophrenia, their mode of transmission is complex[28]. 
The genetic architecture of schizophrenia is consistent with either 1) different genes of major 
effect across different families or 2) multiple, relatively common genes, each with a smaller 
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effect on vulnerability[27]. Because of this, detection of schizophrenia susceptibility loci was 
expected to require large numbers of families, ascertained according to standardized procedures. 
The ISHDSF was designed to accomplish these goals. 
 
Families were ascertained through 39 in-patient psychiatric care facilities serving over 95% of 
the population of Ireland and Northern Ireland. Hospital records and personal interviews with 
facility staff (including psychiatrists, nurses, and medical record librarians) were used to identify 
families with at least two individuals who might have psychotic illness. Approximately 1000 
families identified in this way were subjected to an initial screening. The field criterion for 
follow-up and exhaustive study was families with two or more first-, second-, or third- degree 
relatives who, according to the field psychiatrist, met DSM-III-R criteria for schizophrenia or 
poor-outcome schizoaffective disorder (PO-SAD). No exclusion criteria were used. This meant 
for example, a family might be included that met entry criteria, but also had individuals with 
alcohol dependence or major depression. The decision to include PO-SAD as a possible 
inclusion criterion was based on results from family and adoption studies suggesting a common 
genetic basis for this condition and schizophrenia[29, 30]. 
 
From families who met the above preliminary screening criteria, an individual was contacted to 
provide a family pedigree and also to help decide which family members would be interviewed 
and sampled for DNA. General rules for these decisions included the following: 1) sample all 
affected individuals, 2) sample all “connecting” individuals situated between affecteds within the 
family pedigree, 3) sample all first-degree relatives of affecteds ages 16 and above, and 4) if a 
key individual is unaffected but cannot be sampled, attempt to sample up to 3 siblings. 
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Attempts were made to personally interview all traceable and cooperative family members 
residing in Ireland, Northern Ireland, or cities in England. The study authors estimate they 
interviewed 88% of traceable living probands and 86% of traceable living relatives. 
 
The field team consisted of psychiatrists and social scientists with experience in mental health or 
surveys. Whenever possible, a psychiatrist interviewed individuals with suspected psychosis, 
while social scientists generally interviewed unaffected individuals. Thus, interviewers were not 
blind to the probable history of psychopathology in interviewees. 
 
The assessment instrument was a modified version of the Structured Interview for DSM-III-R 
Diagnosis (SCID)[31] for selected disorders including major depression, psychosis and mania; 
and the Structured Interview for Schizotypy (SIS)[32] for schizophrenia spectrum personality 
disorders. In almost all cases of schizophrenia or schizoaffective disorder (98.6%), psychiatric 
in-patient records were obtained and abstracted, as well. Two psychiatrists blinded to pedigree 
and genotype data then reviewed all available diagnostic information. Diagnostic agreement was 
excellent with a kappa of 0.94. 
 
On the basis of the best available information from twin and adoption studies, several diagnostic 
categories were defined for this study, which were intended to reflect the underlying relationship 
of the various conditions[33]. The definitions of affection were: 1) narrow, to capture “core 
schizophrenia phenotypes”, 2) intermediate, which in addition to those meeting narrow criteria 
included individuals with schizotypal personality disorder and all other nonaffective psychotic 
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disorders, 3) broad, including all the previous, plus individuals with psychotic affective disorders 
and paranoid, avoidant, and/or schizoid personality disorders. Final inclusion criteria for the 
ISHDSF used the above diagnostic classification and can be stated as follows: include families 
with two or more affected first-, second-, or third-degree relatives with an intermediate 
diagnosis, one or more of whom also met criteria for a narrow diagnosis. The birth month and 
year were recorded for all individuals in the sample. The final sample included 277 pedigrees 
with 1,770 individuals. Using the intermediate definition of affected, the sample included 837 
affected individuals. Approximately 67% were male and the average age at the time of 
evaluation was 45.9 years. For the purposes of this study, cases were defined by the intermediate 
set of criteria described above. Cases defined using the other criteria were also examined, but 
results were essentially the same as those discussed below. 
 
There are at least two methodological limitations of the ISHDSF that may be relevant to the 
present study. First, the sample is not truly an “epidemiologic” sample, since ascertainment 
depended partly on the recollections of health care professionals. Second, interviewers were not 
blind to knowledge of psychopathology in the subject’s relatives. Interviewers were repeatedly 
cautioned to discount any such knowledge during their clinical assessments, but this is a 
potential source of bias from the diagnostic phase of the ISHDSF. 
 
The affected individuals from the ISHDSF constituted the sample of cases. Controls were from 
the general population of Ireland. Information on numbers of births for each month was obtained 
from the Central Statistics Office (CSO) of Ireland, covering the years 1976-2000. General 
population births by quarter were obtained for the years 1900-2000. One unavoidable limitation 
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of the available data is that the range of birth years for the general population was different from 
that of the cases, when using birth month data. This was the reason for also examining births by 
quarter. 
 
By using general population numbers to form the control sample, some individuals with 
schizophrenia were inevitably included as ‘controls’. It was assumed that the prevalence of 
schizophrenia in the general population was low enough so that this effect was negligible to a 
first approximation. 
 
Testing for an association between season of birth and schizophrenia: Information on cases was 
taken from the ISHDSF, as described above. Information on controls was taken from the Irish 
CSO, as described. A chi square test was used to determine whether there was a difference 
between the monthly birth frequencies in the schizophrenic and control groups. Expected 
numbers of births for each month were derived by multiplying the observed monthly birth 
frequencies for control patients by the total number of schizophrenic patients. The list of 
observed and expected numbers of monthly schizophrenic births were compared using a chi 
square test with 11 degrees of freedom. 
 
For each month, the average daily birth frequency was calculated for both groups as follows. 
First, the fraction of the total group born in a given month was calculated as the count of 
individuals born in that month divided by the number of individuals in the group. Next, the 
average daily birth frequency was determined by dividing the fraction born in that month by the 
number of days in the month. For February, the number of days used was 28.25, to 
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approximately account for the effect of leap years. This daily birth frequency was graphically 
plotted to directly compare trends across the year for both groups. 
 
Power Simulations 
 
Design: The gene-environment interaction hypothesis discussed above (see Introduction) raises 
several questions. Under such a hypothesis, is there any justification for altering the standard 
approach to searching for disease susceptibility loci? Specifically, in a case-control study 
designed to test for an association between genotype and schizophrenia, is there any justification 
for restricting the sample of schizophrenics to those born only in "bad" (i.e. winter-spring) 
months? Such an approach would necessarily lead to a smaller sample size. However, it is 
conceivable that the loss of power associated with this could be more than offset by a gain in 
power due to a more homogenous set of cases. What factors are most critical in determining 
power to detect genetic associations, assuming gene-environment interaction? In order to gain 
insight into these questions, Monte Carlo computer simulations were conducted to examine 
power to detect genetic association under a variety of plausible scenarios and using two different 
analytic approaches. 
 
These computer simulations all followed the same basic steps: 1) simulate a set of cases and 
controls, including genotypes and month of birth for each individual, 2) using the genotypes and 
month of birth, simulate phenotype (i.e., schizophrenia or not) for each individual, 3) conduct a 
statistical test of association using the simulated case-control data, and record the resulting p-
value. 
14 
 
For each set of simulation conditions, these three steps were repeated until 1000 tests of 
association had been conducted. Power to detect association for a given set of conditions was 
defined as the fraction of the 1000 statistical tests of association with p-values < 0.05. 
 
All simulations were scripted using Python, version 2.5.1, which includes a pseudo-random 
number generating module. The effect of several variables on power to detect genetic 
associations with schizophrenia was evaluated by simulating data sets assuming different sets of 
conditions. A condition was defined as one particular combination of sample size, gene effect 
size, minor allele frequency, and phenotype model (each defined below). A total of 8 conditions 
were simulated (see Table 1) and each was analyzed using two different approaches, giving a 
total of 16 estimates of power. 
 
Simulation conditions and procedures: Sample size was either 1000 cases and 1000 controls, or 
500 cases and 500 controls. Minor allele frequency (MIF), which here refers to the population 
frequency of the disease allele, was set to either 0.2 or 0.3, consistent with observed MIFs for 
many human single nucleotide polymorphisms[34]. Genotype for an individual was simulated by 
randomly choosing two alleles independently, according to the MIF. 
 
As noted above, month of birth and was also simulated for all individuals. To simulate month of 
birth, an equal probability of being born on any day of the year was assumed. A cumulative 
probability distribution was constructed to reflect the probability of being born in January, 
February, March, etc. For all months except February, the probability of being born in that 
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month was simply the number of days in the month divided by 365. For the month of February, 
the number of days was set equal to 28.25, to include the effect of leap years. Thus, the 
probability of being born in February was set as 28.25 divided by 365. Month of birth for an 
individual was simulated by randomly choosing a month according to this probability 
distribution. 
 
Once month of birth and genotype were simulated for a given individual, these were combined 
using a probabilistic model, model1, to determine phenotype: 
 
probability of disease = 0.01 + (number of disease alleles)*(effect size) + (bad month)*(number 
of disease alleles)*(effect size) 
 
Here, “disease” refers to schizophrenia. All individuals were assumed to have a baseline risk of 
schizophrenia of 0.01 (approximately equal to the lifetime prevalence of schizophrenia[35]), 
independent of their month of birth and their genotype at the susceptibility locus. In addition, 
each disease allele conferred a specific amount of risk. This was termed the gene's effect size; 
effect sizes used for model1 were 0.001 and 0.002. March, April and May were designated as 
high-risk birth months (see Results, below). A binary variable called "bad month" was created 
that took a value of 1 for individuals born in March, April, or May and a value of zero for 
individuals born in other months. All of these variables were then combined using the equation 
for model1 to produce a probability of disease. 
 
As an example of the use of model1, consider a simulated individual with one disease allele 
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(genotype Aa, with 'a' standing for the disease allele) and born in the month of December (thus 
"bad month" = 0) with a gene effect size of 0.002. The probability of this person having 
schizophrenia by model1 would then be: 
 
0.01 + (1)*(0.002) + (0)*(1)*(0.002) = 0.012 
 
The phenotype in this case would be determined by randomly drawing a number between 0 and 1 
(all numbers equally likely); if the number were less than or equal to 0.012, this individual would 
have schizophrenia, otherwise not. Such individuals were simulated until the specified numbers 
of cases and controls were reached. 
 
We also investigated a variation of this model (model2), where the susceptibility locus only 
conferred risk on those individuals born in high-risk months. This alternate model for phenotype 
developement can be expressed as: 
 
probability of disease = 0.01 + (bad month)*(number of disease alleles)*(effect size) 
 
Note that, in this model, there is no elevated risk associated with the disease allele in individuals 
who are born in "good" months. The effect sizes used in this model were 0.002 and 0.004; these 
numbers were different from those used in model1. This was done so that individuals in the 
highest risk category (two disease alleles and born in a bad month) would have the same risk in 
model1 and model2. Note that both model1 and model2 are probabilistic. This means that the 
simulated phenotype for an individual with two disease alleles could be "normal," and 
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conversely, that the simulated phenotype for an individual with no disease alleles could be 
"schizophrenia." 
  
Analysis of simulated data: Once the specified numbers of cases and controls were simulated, the 
entire simulated data set was analyzed to test for any evidence of association between genotype 
and phenotype. Two separate chi square tests were conducted for each set of simulated data. In 
the first, the observed genotype frequencies across all cases were compared to the expected 
frequencies based on the controls. In the second test, the observed genotype frequencies in the 
subset of cases born in “bad” months (March, April, or May) were compared to the expected 
frequencies. This second test represents an alternative approach to searching for susceptibility 
loci. Again, the primary purpose of these simulations was to determine if there was any rationale 
for choosing this second approach over, or at least in addition to, the standard approach (using 
the entire set of cases and controls). That is, are there circumstances when using only a subset of 
the cases would actually result in a gain in power to detect genetic associations? 
 
Analysis of the Irish Case Control Study of Schizophrenia 
 
Design: As an illustration of the analytic approach used in the power simulations, and to test the 
hypothesis that gene-season of birth interaction influences risk for schizophrenia, data from the 
Irish Case Control Study of Schizophrenia were analyzed (ICCSS). The ICCSS is a sample of 
schizophrenic and control subjects with genotypes available for several loci within the genome. 
The strategy employed for this study was to 1) select genotyped loci from individuals in the 
ICCSS, and 2) analyze these loci for evidence of association with schizophrenia using all cases, 
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and then using only cases born in March, April, or May. This is exactly the analytic strategy 
employed in the simulations; the main purpose here was to use this strategy with real data. 
 
Sample: The ICCSS is a sample of schizophrenic and control individuals from Ireland and 
Northern Ireland, i.e., the same geographic areas as the ISHDSF. Cases were selected from in- 
and outpatient psychiatric facilities. To be eligible for enrollment, cases had to meet DSM-III-R 
criteria for schizophrenia or schizoaffective disorder with poor outcome. A blinded, expert 
reviewer verified all diagnoses. Controls were selected from several sources, including blood 
donation centers. Controls were eligible if they denied a lifetime history of schizophrenia. 
Potential subjects were included only if all four of their grandparents were born in Ireland or the 
United Kingdom. The number of cases and controls with complete data, and thus used in these 
analyses, varied depending on the marker, but there were approximately 700 cases and 600 
controls. 
 
Marker selection and genotyping: A set of six previously genotyped markers for cases and 
controls was selected for this study. All markers were single nucleotide polymorphisms (SNPs) 
within or near genes one of three genes: IL3, FBXL21, and CSF2RB. The SNPs included in this 
analysis are shown in Table 2, along with the names and descriptions of genes they occur in or 
near. 
 
As noted above, all markers selected for analysis in this study were previously genotyped and 
analyzed, and details of marker genotyping have been described[36]. Briefly, HapMap data and 
existing assays developed by Applied BioSystems were used to select markers. SNPs were 
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selected only if they covered haplotypes with population frequencies > 1%. Genotyping was 
done using the TaqMan method. Genotypes were scored, and all SNPs were checked for 
deviations from Hardy Weinberg equilibrium and for Mendelian consistency. 
 
Statistical Analyses: A chi square test was used to evaluate whether there was any evidence for 
genetic association at each of the markers. For each SNP, the genotype frequencies were derived 
for cases and controls. Expected genotype frequencies were derived using control genotype 
frequencies. Observed genotype frequencies were defined as those observed for the cases. For 
each SNP, a chi square test was performed using all cases, and then a second test was performed 
using only those cases born in March, April, or May. The reason for choosing these specific 
months was that excess schizophrenic births were observed in these months using the ISHDSF 
(see results, Season of birth and schizophrenia in the ISHDSF, below). All controls were used for 
each test. All analyses excluded any cases with missing birthdates or genotypes, and any controls 
missing genotypes. 
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Results 
 
Season of birth and schizophrenia in the ISHDSF 
 
The first part of this studied aimed to determine whether there is evidence that season of birth 
influences risk for schizophrenia using cases from the ISHDSF and general population controls. 
Table 3 shows, for each month of birth, the observed counts of cases and controls, as well as the 
expected number of cases based on the observed control frequencies. Comparing the observed 
and expected counts for cases gave a chi square value of 19.44 (p-value 0.054, 11 df). Note that 
data on month of birth were available for controls only for the years 1976-2000. The years of 
birth for the cases, however, ranged from 1893-1973. 
 
Table 4 shows, for each quarter of birth (quarter 1 including January, February, or March as the 
month of birth; quarter 2 including April, May, or June; etc.), the observed counts of cases and 
controls, as well as the expected number of cases based on the observed control frequencies. 
Comparing the observed and expected counts for cases gave a chi square value of 7.48 (p-value 
0.058, 3 df). Here, data on quarter of birth for controls was available for the years 1900-2000. 
 
In order to examine the data visually for any possible trends, data for cases and controls were 
plotted together. Figure 1 shows daily birth frequency by month for cases and controls. Daily 
birth frequency is the fraction of births in a given month divided by the number of days in that 
month. This measure was used so that cases and controls would be on a comparable scale, and so 
that the effect of months with differing lengths would be removed. The figure indicates a trend 
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toward excess of schizophrenic births in the months of March, April, and May, and also an 
apparent birth deficit in the months of August, September, and October. Figure 2 similarly shows 
the daily birth frequency by quarter for cases and controls. Note that the quarters, as defined by 
the calendar, split the months of excess birth (March in quarter 1, April and May in quarter 2). 
Still, there seems to be an excess of schizophrenic births in the first two quarters and a 
concomitant deficit in the second two quarters. As before, month of birth is available for controls 
covering 1976-2000; quarter of birth is available for controls covering 1900-2000. 
 
As noted in Methods, the ISHDSF had several diagnostic categories for schizophrenia, ranging 
from narrowly-defined schizophrenia to a much broader phenotype including categories such as 
paranoid, avoidant and schizoid personality disorder; mood incongruent and mood congruent 
psychotic affective illness; and delusional disorder. The analyses above were repeated with each 
diagnostic category. The trends observed were essentially the same as those shown, with excess 
schizophrenic births in March, April, and May. The lowest p-value (0.014) was for a broad 
definition of affection, which included schizophrenia, poor-outcome schizoaffective disorder, 
simple schizophrenia, schizotypal personality disorder, schizophreniform disorder, delusional 
disorder, atypical psychosis, good-outcome schizoaffective disorder, psychotic affective illness, 
and paranoid, avoidant, and schizoid personality disorders. 
 
Power simulations 
 
The second part of this study was designed to explore the power to detect genetic associations 
under a variety of plausible hypotheses regarding how genes and season of birth might interact to 
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produce risk for schizophrenia. Table 5 shows the results of the power simulations using model1, 
i.e., where the susceptibility locus increases risk for schizophrenia in all months of birth, but 
more so for March, April, and May. For analyses with all cases and all controls, power ranges 
from 42% to 96%. The most significant gains in power appear to be associated with increasing 
gene effect size (e.g. with 500 cases/controls and MIF = 0.2, power increases from 42% to 72% 
as the gene effect size increases from 0.001 to 0.002). For analyses that restrict cases to those 
born in March, April, and May, power is always less than the corresponding conditions using the 
entire set of cases. When cases are restricted to "bad" birth months, power to detect genetic 
association ranges from 25% to 85%. As with analyses using the full set of data, the most 
marked jumps in power are associated with increased gene effect size. 
  
Table 6 shows the results of the power simulations using model2, i.e., where the susceptibility 
locus increases risk for schizophrenia only among those born in March, April, or May. The most 
marked difference from the simulations using model1 (Table 5) is that power to detect genetic 
association is almost always greater for the analyses using cases restricted to "bad" birth months. 
For example, with 1000 cases/controls, a gene effect size of 0.004, and MIF = 0.2, power is 82% 
for when cases are restricted, while power is 48% using all cases. For analyses with all cases and 
all controls, power ranges from 28% to 51%. For analyses with cases restricted to those born in 
bad months, power ranges from 29% to 87%. When the gene effect size was 0.002, power using 
the restricted set of cases was approximately equal to the power using all cases with 500 
cases/controls. The difference between the two analytic strategies was substantially greater for a 
gene effect size of 0.004. 
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Analysis of the Irish Case Control Study of Schizophrenia 
 
Table 7 contains the results of the analysis of six SNPs for evidence of association with 
schizophrenia using the ICCSS. Significant evidence of association (p < 0.05) was found using 
all cases for markers rs2284031, rs909486, and rs31555. Significant evidence of association 
using the subset of cases born in March, April, and May was found for only one SNP, rs31555. 
Restricting cases to the specified birth months resulted in three instances of an increased chi 
square value (decreased p-value), for SNPs rs1859427, rs31555, and rs3914025. In one of these 
instances (rs31555), the p-value decreased from ~0.038 to ~0.011, even though the number of 
cases decreased from 692 to 173. 
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Discussion 
 
This multi-part study sought to explore, from several perspectives, season of birth as a potential 
risk factor for schizophrenia. First, this study examined whether there was evidence to suggest 
that months of birth are different in schizophrenics from the ISHDSF vs. the Irish general 
population using a case-control design. Second, power simulations were conducted to compare 
different analytic strategies given different parameter values and assumptions about the 
interaction of genetics and season of birth to produce risk for schizophrenia. Third, actual genetic 
data from the ICCSS were analyzed using the strategies studied as part of the simulations. 
 
The first part of this study used a case-control design. Cases were individuals diagnosed with 
schizophrenia from the ISHDSF. Controls were the general population of Ireland. The chi square 
test of whether months of birth differed between cases and controls was marginally significant 
(p-value 0.054). Visual inspection of the data revealed a trend toward increased schizophrenic 
births in March, April, and May. Taken together, these results suggest that season of birth is a 
risk factor for schizophrenia for cases in the ISHDSF. The chi square test is relatively insensitive 
to a positive finding for the following reason: it does not take into account the expected month-
to-month correlations in birth rates[17]. More specifically, if birth rate truly does change over the 
course of the year, it would be expected to gradually rise and fall, as opposed to suddenly rising 
in one month, falling in the next, etc. The insensitivity of the chi square test to these different 
possibilities can be understood by considering the following: randomly shuffling months, so that 
an implausibly jagged rise and fall of schizophrenic birth rates were observed, would give the 
same chi square value. Thus, a better statistical test would be one that accounted for the expected 
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inter-month correlations of birth rates. Moreover, while it is certainly possible that any individual 
month with an excess of schizophrenic births could be a random occurrence, the random 
consecutive occurrence of excess births across three months is much less likely. Thus, it seems 
reasonable to conclude that season of birth is different for schizophrenics and controls, with an 
excess of schizophrenic births in the winter-spring months of March, April, and May. It is 
interesting that such an effect was observed in light of two previous findings: 1) power analyses 
which suggest that thousands of subjects are necessary for a reasonable chance at detecting a 
season of birth effect[37], and 2) findings which suggest that excess winter-spring schizophrenic 
births are limited to cases without a family history[15]. 
 
The case-control approach used above is subject to a number of limitations. First, the control 
data were taken from aggregate population-level data provided by the Irish CSO. The only 
information available was the total number of individuals born in Ireland by month for each year 
from 1976 to 2000, and by quarter from 1900 to 2000. Since this is data for the entire population, 
it is reasonable to suppose that the number of females is approximately equal to the number of 
males, and obviously, chronological ages can be determined. Other potential schizophrenia 
covariates are, however, unavailable. As discussed above, increased risk associated with season 
of birth is thought to be a proxy for maternal infection or some other seasonally varying toxic 
environmental exposure. A direct measure of any of these putative factors would be desirable, 
since one could directly test whether the factor accounts for the observed relationship between 
season of birth and schizophrenia. Studies of this kind have been conducted[38], but are 
generally difficult because of time and resource constraints. 
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Second, we had to assume that the individuals represented by the aggregate population data were 
not schizophrenic. Because the prevalence of schizophrenia is approximately 1%, this is a 
reasonable first approximation. The effect of including some schizophrenics in the set of controls 
should, in fact, make detection of an association between season of birth and schizophrenia more 
difficult, since such a misclassification would tend to make the control and schizophrenic groups 
more similar. This design, with general population controls, has been used previously to study 
schizophrenia and season of birth[26]. 
 
Third, for the month-to-month analysis in Figure 1, the controls were born over a different range 
of years as compared to the schizophrenics. It was assumed that monthly birth frequencies would 
not vary across time, i.e., that the observed monthly birth frequencies would be the same for a 
control group drawn from the same range of birth years as the schizophrenic group. To more 
directly test this assumption, quarter of birth and schizophrenia were examined using the same 
set of ISHDSF cases and CSO Irish controls born between 1900 and 2000. As shown in Figure 2, 
the ranges of birth years for the cases and controls still do not exactly match, but the ranges are 
more closely matched than for the analysis by month. The analysis by quarter produced 
essentially the same result as the first: a marginally significant p-value (0.058) and a trend 
toward increased schizophrenic births in quarters 1 and 2 (see Figure 2). 
 
The power simulations involved two distinct models for how genes and season of birth could 
combine to determine risk for schizophrenia. In the first, model1, the susceptibility gene 
increased risk for all individuals, but more so for those born in months 3-5. In the second, 
model2, the susceptibility gene only increased risk for individuals born in months 3-5, but not at 
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all for individuals born in other months. Under model1, there was greater power to detect genetic 
associations when all cases are used in the analysis. Under model2, there was generally more 
power to detect genetic associations when the pool of cases is restricted to those individuals born 
in months 3-5. This is in spite of the fact that such restriction decreased sample size. Such a 
finding suggests that in actual studies of genetic association, restricting the set of cases may 
increase the likelihood of detecting true positive associations. Since the only additional data 
required for such an analysis would be season of birth, it should be relatively easy to implement. 
As always, the number of tests should influence one's interpretation of the resulting p-values, and 
statistical correction for multiple testing is advisable[39]. As with any set of computer 
simulations, the conclusions from these simulations are, strictly speaking, only applicable to the 
conditions studied. Furthermore, this approach requires assumptions regarding the relationship of 
genotype and phenotype, MIF, and gene effect size. Care was taken to ensure that the values 
used for the simulation conditions were plausible[2, 34]. 
 
Based on the findings of the power simulations, data on 6 SNP markers from the ICCSS were 
analyzed using all cases, and then using cases born in months 3-5. In one of six cases, an initially 
significant result became more significant when cases were restricted to bad months of birth (for 
SNP rs31555). As shown in Table 2, this SNP is associated with the gene FBXL21, an F-box 
containing protein that functions in ubiquitin-mediated proteolysis. The results for the other SNP 
associated with this gene, rs1859427, were nonsignificant, however, the p-value did decrease 
from 0.342 to 0.175. Thus, restriction of cases was associated with larger chi square values for 
both SNPs associated with this gene. There was one other marker that showed an increased chi 
square value with the restricted set of cases, marker rs3914025 associated with the IL3 gene. The 
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other maker associated with IL3 and the two remaining markers all had decreased chi square 
values with the restricted set of cases. Findings of genetic association are often plagued by failed 
attempts at replication. Thus, these results should be interpreted with a great deal of caution and 
skepticism. However, these tests do serve as a general illustration of the procedure suggested by 
the simulations above. 
 
In all the tests for genetic association, all controls were used, regardless of whether the cases 
were restricted by month of birth or not. The validity of this procedure requires the following 
assumption: genotype frequencies are the same across all months of birth for the control 
individuals. Unfortunately, it is not possible to directly test this assumption, since the only 
information available for most controls was their genotype and the fact that they denied any 
history of schizophrenia. It is conceivable that this assumption is false, i.e., certain genotypes 
combined with certain months of birth lead to increased overall mortality in the general 
population, perhaps via maternal infections. 
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Conclusion 
 
In summary, this examination of season of birth and schizophrenia suggests that birth in the 
months of March, April, or May is associated with increased risk for schizophrenia, even in 
individuals with highly familial schizophrenia. The power simulations demonstrate that power to 
detect genetic associations may be increased by restricting cases of schizophrenia to those born 
in months of elevated risk. Specifically, this was the case when a susceptibility locus conferred 
risk for schizophrenia among those born in high-risk months, but no risk to those born in other 
months. Finally, analysis of six SNPs for genetic association revealed that for the gene FBXL21, 
evidence for association was stronger when cases were restricted to those born in high-risk 
months. For future work, investigators conducting genome-wide association studies for 
schizophrenia susceptibility loci should consider using subject dates of birth as an 
“environmental” risk factor, to probe for gene-environment interactions. Such an approach could 
result in substantially increased power to detect susceptibility loci for schizophrenia. 
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Tables 
 
Box 1. DSM-III-R criteria for schizophrenia. 
1. Characteristic symptoms: Two or more of the following, each present for much of the time 
during a one-month period (or less, if symptoms remitted with treatment).  
• Delusions 
• Hallucinations 
• Disorganized speech 
• Grossly disorganized behavior (e.g., dressing inappropriately, crying frequently) or 
catatonic behavior 
• Negative symptoms—affective flattening (lack or decline in emotional response), 
alogia (lack or decline in speech), or avolition (lack or decline in motivation) 
 
If the delusions are judged to be bizarre, or hallucinations consist of hearing one voice 
participating in a running commentary of the patient’s actions or of hearing two or more voices 
conversing with each other, only that symptom is required above. The speech disorganization 
criterion is only met if it is severe enough to substantially impair communication. 
 
2. Social/occupational dysfunction: For a significant portion of the time since the onset of the 
disturbance, one or more major areas of functioning such as work, interpersonal relations, ore 
self-care, are markedly below the level achieved prior to the onset. 
 
3. Duration: Continuous signs of the disturbance for at least six months. This six-month 
period must include at least one month of symptoms (or less, if symptoms remitted with 
treatment). 
 
 
 
Table 1. Simulation conditions. 
Parameter Values used in simulations 
Number of cases/controls 500/500 
1000/1000 
 
Gene effect sizes For Model1: 0.001, 0.002 
For Model2: 0.002, 0.004 
 
Minor allele frequencies (MIFs) 0.2 
0.3 
 
Phenotype models Model1: disease alleles confer risk for persons born in all 
months, more risk if born in month 3, 4, or 5 
Model2: disease alleles only confer risk for persons born 
in months 3, 4, or 5. 
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Table 2. Single nucleotide polymorphism (SNP) markers used in this study. 
SNP Associated gene Description of associated gene 
rs1859427 FBXL21 F-box containing protein, functions in ubiquitin-mediated 
protein breakdown 
rs31555 FBXL21 F-box containing protein, functions in ubiquitin-mediated 
protein breakdown 
rs2069803 IL3 
 
interleukin-3 
rs3914025 IL3 
 
interleukin-3 
rs2284031 CSF2RB shared subunit of receptors for IL3, CSF2, and IL5; initiates 
signal transduction after ligand binding 
rs909486 CSF2RB shared subunit of receptors for IL3, CSF2, and IL5; initiates 
signal transduction after ligand binding 
 
 
 
Table 3. Observed and expected schizophrenia cases by month, using data from the ISHDSF and 
general population controls from Ireland. 
 cases observed controls observed control frequencies cases expected 
Jan 65 123252 0.082938778 59.71591995 
Feb 56 114937 0.077343445 55.68728046 
Mar 79 130623 0.087898874 63.28718894 
Apr 72 125996 0.084785271 61.04539521 
May 78 131482 0.088476912 63.70337671 
Jun 56 124114 0.083518835 60.13356123 
Jul 66 128671 0.086585333 62.34143978 
Aug 46 123970 0.083421935 60.06379285 
Sep 54 125600 0.084518795 60.85353216 
Oct 43 122764 0.082610393 59.47948266 
Nov 50 115511 0.077729701 55.96538498 
Dec 55 119140 0.080171729 57.72364507 
Total 720 1486060 1 720 
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Table 4. Observed and expected schizophrenia cases by quarter, using data from the ISHDSF 
and general population controls from Ireland. 
 cases observed controls observed control frequencies cases expected 
Quarter 1 200 1726052 0.249793051 179.850997 
Quarter 2 206 1822911 0.263810419 189.9435016 
Quarter 3 166 1741833 0.252076867 181.4953441 
Quarter 4 148 1619132 0.234319663 168.7101573 
Total 720 6909928 1 720 
 
 
 
Table 5. Results of power simulations using model1, i.e., disease allele confers risk on all 
persons, but more risk on persons born in months 3, 4, or 5. Results for analyses with all cases 
and with cases restricted to those born in high-risk months are shown. 
number of 
cases, controls 
gene effect size minor allele 
frequency 
power: all cases power: only 
cases born in 
mo 3-5 
0.2 0.424 0.252 0.001 
0.3 0.45 0.294 
0.2 0.723 0.541 
500 
0.002 
0.3 0.771 0.625 
0.2 0.56 0.36 0.001 
0.3 0.626 0.443 
0.2 0.915 0.807 
1000 
0.002 
0.3 0.957 0.848 
 
 
 
Table 6. Results of power simulations using model2, i.e., disease allele confers risk only on 
persons born in months 3, 4, or 5. Results for analyses with all cases and with cases restricted to 
those born in high-risk months are shown. 
number of 
cases, controls 
gene effect size minor allele 
frequency 
power: all cases power: only 
cases born in 
mo 3-5 
0.2 0.277 0.289 0.002 
0.3 0.279 0.276 
0.2 0.344 0.575 
500 
0.004 
0.3 0.375 0.617 
0.2 0.308 0.381 0.002 
0.3 0.33 0.428 
0.2 0.479 0.82 
1000 
0.004 
0.3 0.513 0.874 
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Table 7. Results of genetic association analyses with six single nucleotide polymorphism (SNP) 
markers, including all cases and restricting cases to those born in March, April, or May. 
SNP 
marker 
Associated 
gene 
Using all cases Using cases born in March, 
April, or May 
  Chi square p-value Chi square p-value 
rs2284031 CSF2RB 7.379289268 0.024980878 1.291983631 0.524142432 
rs909486 CSF2RB 9.99247693 0.00676334 3.369596814 0.18548182 
rs1859427 FBXL21 2.147428809 0.341736808 3.484086426 0.175162141 
rs31555 FBXL21 6.538706984 0.038031006 8.967530259 0.011290822 
rs2069803 IL3 3.977176475 0.136888543 2.41160953 0.299450915 
rs3914025 IL3 2.607192431 0.27155347 4.287835042 0.117194829 
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Figures 
 
 
Figure 1. Daily birth frequency by month for ISHDSF cases and general population controls. 
 
 
 
 
 
 
Figure 2. Daily birth frequency by quarter for ISHDSF cases and general population controls. 
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Appendix. Python script for power simulations. 
 
import random, stats 
 
#these are the number of cases (=number of controls)... 
sample_sizes = [1000, 500] 
#these are effect sizes (see pheno_model below)... 
effect_sizes = [0.002, 0.004] 
#minor allele frequencies... 
mifs = [0.2, 0.3] 
 
#model for phenotype, based on number of disease alleles and season of 
birth... 
def pheno_model(dz, sob, effect_size): 
 return 0.01 + dz*(effect_size) + sob*(dz*(effect_size)) 
 
#model for phenotype, based on number of disease alleles and season of 
birth... 
def pheno_model2(dz, sob, effect_size): 
 return 0.01 + sob*(dz*(effect_size)) 
 
 
#bad_months = birth months associated with increased risk of schizophrenia... 
bad_months = [3, 4, 5] 
 
daysInYear = 365.0 
#days in month; Feb is approximation, based on fact of leap years... 
dim = [ 31, 28.25, 31, 30, 31, 30, 31, 31, 30, 31, 30, 31 ] 
 
#create cumulative prob dist for birth month 
cp = [] 
lb, ub = 0.0, 0.0 
for m in dim: 
 lb = ub 
 ub = ub + (m/daysInYear) 
 cp.append((lb, min(ub, 1.0))) 
 
#simulates number of disease alleles at a locus, given mif 
def sim_genotype(mif): 
 r1 = random.random() 
 r2 = random.random() 
 g1, g2 = 0, 0 
 if r1 < mif: 
  g1 = 1 
 if r2 < mif: 
  g2 = 1 
 return g1 + g2 
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#simulates a birth month according to the cumulative prob distribution 
above... 
def sim_bd(cp): 
 r = random.random() 
 for i, (lb, ub) in enumerate(cp): 
  if r > lb and r < ub: 
   return i + 1 
   break 
 
#simulates phenotype, given number of dz alleles and whether person was born 
in a 'bad month'... 
def sim_pheno(dz, sob): 
 pheno = 0 
 r = random.random() 
 if dz == 0: 
  phenocut = 0.01 
 else: 
  phenocut = pheno_model2(dz, sob, effect_size) 
 if r < phenocut: 
  pheno = 1 
 return pheno 
  
#::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
#simulations start here... 
 
for n in sample_sizes: 
 for effect_size in effect_sizes: 
  for mif in mifs: 
   
   #make output file... 
   outputfilename = 'power3_' + str(n) + '_' + str(effect_size) + '_' 
+ str(mif) 
   outfile = open(outputfilename, 'w') 
 
   #print sim parameters...  
   print >>outfile, 'number of cases (=number controls):', n 
   print >>outfile, 'effect size:', effect_size 
   print >>outfile, 'minor allele frequency:', mif 
   print >>outfile, 'phenotype model: 0.01 + dz*(effect_size) + 
sob*(dz*(effect_size))' 
   print >>outfile, '\n' 
  
   #starting simulations... 
   ctsiggood, ctsigbad, ctsigsep, ctsig, cttotal = 0, 0, 0, 0, 0 
   for iter in range(1000):  
    #sim controls... 
    controls = []  
    while len(controls) < n: 
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     sob = 0 
     dz = sim_genotype(mif) 
     mo = sim_bd(cp) 
     if mo in bad_months: 
      sob = 1  
     pheno = sim_pheno(dz, sob) 
     if pheno == 0: 
      controls.append((dz, mo, sob, pheno)) 
    #sim cases... 
    cases = []  
    while len(cases) < n: 
     sob = 0 
     dz = sim_genotype(mif) 
     mo = sim_bd(cp) 
     if mo  in bad_months: 
      sob = 1  
     pheno = sim_pheno(dz, sob) 
     if pheno == 1: 
      cases.append((dz, mo, sob, pheno)) 
 
    #keys are, for each category, number of bad disease alleles; 
values are counts of people in that category with that number of dz alleles 
    countsCases_goodSOB, countsCases_badSOB, countsCases, 
countsControls = {0:0, 1:0, 2:0}, {0:0, 1:0, 2:0}, {0:0, 1:0, 2:0}, {0:0, 
1:0, 2:0} 
    total_badSOB_cases, total_goodSOB_cases = 0, 0 
    for i, (dz_case, mo_case, sob_case, pheno_case) in 
enumerate(cases): 
     dz_control, mo_control, sob_control, pheno_control = 
controls[i] 
     if sob_case == 1: 
      countsCases_badSOB[dz_case] = 
countsCases_badSOB[dz_case] + 1 
      total_badSOB_cases += 1 
     elif sob_case == 0: 
      countsCases_goodSOB[dz_case] = 
countsCases_goodSOB[dz_case] + 1 
      total_goodSOB_cases += 1 
     countsControls[dz_control] = 
countsControls[dz_control] + 1 
     countsCases[dz_case] = countsCases[dz_case] + 1 
 
    #get expected numbers of cases, based on frequencies of 
controls with 0, 1, or 2 disease alleles 
    expectedCases_goodSOB, expectedCases_badSOB, expectedCases = 
[], [], [] 
    for numDzAlleles in [0, 1, 2]: 
     freq_controls = countsControls[numDzAlleles] / 
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float(n)  
     expectedCases_goodSOB.append(freq_controls * 
float(total_goodSOB_cases)) 
     expectedCases_badSOB.append(freq_controls * 
float(total_badSOB_cases)) 
     expectedCases.append(countsControls[numDzAlleles]) 
 
    #calculate chisquared statistics... 
    #this is for association among just those born in bad months 
    chisqbad, pvalbad = stats.lchisquare([countsCases_badSOB[0], 
countsCases_badSOB[1], countsCases_badSOB[2]], expectedCases_badSOB) 
    #this is for association among just those born in good 
months 
    chisqgood, pvalgood = 
stats.lchisquare([countsCases_goodSOB[0], countsCases_goodSOB[1], 
countsCases_goodSOB[2]], expectedCases_goodSOB) 
    #this is for association, using all persons, but splitting 
into obs/expected counts into good and bad cells 
    chisqsep, pvalsep = 
stats.lchisquare([countsCases_goodSOB[0], countsCases_goodSOB[1], 
countsCases_goodSOB[2], countsCases_badSOB[0], countsCases_badSOB[1], 
countsCases_badSOB[2]], expectedCases_goodSOB + expectedCases_badSOB) 
    #this is for association, using all persons 
    chisqall, pvalall = stats.lchisquare([countsCases[0], 
countsCases[1], countsCases[2]], expectedCases) 
    if pvalbad < 0.05: 
     ctsigbad += 1 
    if pvalgood < 0.05: 
     ctsiggood += 1 
    if pvalsep < 0.05: 
     ctsigsep += 1 
    if pvalall < 0.05: 
     ctsig += 1 
    cttotal += 1 
    print >>outfile, [countsCases_badSOB[0], 
countsCases_badSOB[1], countsCases_badSOB[2]], [countsCases_goodSOB[0], 
countsCases_goodSOB[1], countsCases_goodSOB[2]], [countsControls[0], 
countsControls[1], countsControls[2]], pvalbad, pvalgood, pvalsep, pvalall 
     
   #print final tally of significant / nonsignificant tests... 
   print >>outfile, ctsiggood, ctsigbad, ctsigsep, ctsig, 
cttotal  
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